🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label pilot study of the safety and tolerability of 7% hype...
Status
Completed
Location
University of North Carolina
Start Date
2007-09
Trial ID
NCT00546663
Treatments Being Tested
Cat allergy is an increasingly prevalent condition, affecting 10-15% of pat...
Status
Completed
Location
Alpha Medical Research
Start Date
2009-03
Trial ID
NCT00867906
The purpose of the study is to test how well 2 different medications stop a...
Status
Completed
Location
University of New Mexico
Start Date
2005-12
Trial ID
NCT00273689
Treatments Being Tested
A study evaluating efficacy and safety of repeated doses of PT027 compared ...
Status
Completed
Location
Research Site
Start Date
2022-09-28
Trial ID
NCT05555290
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
The COVID-19, a pandemic as declare by WHO1, has a devastating impact on he...
Status
Unknown
Location
Sheikh zayed medical college & hospital
Start Date
2021-07-01
Trial ID
NCT04979923
Treatments Being Tested
This is a multi-center 3-month study to determine the variation in ProAir D...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2022-03-01
Trial ID
NCT05241288
Treatments Being Tested
A randomized, 2-period crossover, single-center, open-label study for viral...
Status
Completed
Location
Theravance Biopharma Investigational Site
Start Date
2021-05-04
Trial ID
NCT04681079
Treatments Being Tested
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested